Function
Mitochondrial fatty acid beta-oxidation enzyme that catalyzes the third step of the beta-oxidation cycle for medium and short-chain 3-hydroxy fatty acyl-CoAs (C4 to C10). Plays a role in the control of insulin secretion by inhibiting the activation of glutamate dehydrogenase 1 (GLUD1), an enzyme that has an important role in regulating amino acid-induced insulin secretion. Plays a role in the maintenance of normal spermatogenesis through the reduction of fatty acid accumulation in the testes.
Biological Context
Subcellular Location: Mitochondrion matrix
Tissue Specificity: Expressed in liver, kidney, pancreas, heart and skeletal muscle
Disease Association: 3-alpha-hydroxyacyl-CoA dehydrogenase deficiency (HADH deficiency) : An autosomal recessive, metabolic disorder with various clinical presentations including hypoglycemia, hepatoencephalopathy, myopathy or cardiomyopathy, and in some cases sudden death. [The disease is caused by variants affecting the gene represented in this entry] | Hyperinsulinemic hypoglycemia, familial, 4 (HHF4) : A form of hyperinsulinemic hypoglycemia, a clinically and genetically heterogeneous disorder characterized by inappropriate insulin secretion from the pancreatic beta-cells in the presence of low blood glucose levels. HHF4 clinical features include hypoglycemic coma, mental retardation due to repeated episodes of hypoglycemia, and seizures. HHF4 inheritance is autosomal recessive. [The disease is caused by variants affecting the gene represented in this entry]
Pathway: Lipid metabolism; fatty acid beta-oxidation
Product Specifications
Mouse anti-Human sapiens (Human) HADH Monoclonal Antibody is a recombinant protein. Suitable for ELISA and Western Blot applications. Explore more Antibody products →


